ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

IKT Inhibikase Therapeutics Inc

1.39
0.05 (3.73%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Inhibikase Therapeutics Inc IKT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.05 3.73% 1.39 13:00:10
개장가 저가 고가 종가 전일 종가
1.38 1.3304 1.51 1.39 1.34
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
19/04/202405:30GLOBEInhibikase Therapeutics Issues Letter to Shareholders and..
03/04/202421:05GLOBEInhibikase Therapeutics Announces Pre-IND Meeting with the..
28/03/202405:15GLOBEInhibikase Therapeutics Reports Fourth Quarter and Full Year..
07/03/202422:30GLOBEInhibikase Therapeutics to Provide Trial Update for..
29/02/202406:05GLOBEInhibikase Therapeutics Announces Full Outcomes of its..
07/02/202421:59EDGAR2Form 8-K - Current report
07/02/202421:55GLOBEInhibikase Therapeutics Announces Preliminary Outcomes of..
02/02/202406:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/02/202406:09EDGAR2Form 8-K - Current report
29/01/202423:05GLOBEInhibikase Therapeutics Announces Publication Highlighting..
17/01/202406:31EDGAR2Form 8-K - Current report
17/01/202406:05GLOBEInhibikase Therapeutics Announces Planned Retirement of..
19/12/202322:30GLOBEInhibikase Therapeutics Issues Letter to Shareholders and..
04/12/202322:35GLOBEInhibikase Therapeutics Granted Pre-NDA Meeting with the FDA..
15/11/202306:30GLOBEInhibikase Therapeutics Reports Third Quarter Financial..
07/11/202323:28GLOBECorrecting & Replacing -- Inhibikase Therapeutics to Report..
07/11/202322:00GLOBEInhibikase Therapeutics to Report Second Quarter Financial..
17/10/202306:24EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
16/10/202320:00GLOBEInhibikase Therapeutics Highlights Unblinded Functional..
04/10/202321:30GLOBEInhibikase Therapeutics Receives FDA Orphan Drug Designation..
21/09/202300:23EDGAR2Form 8-K - Current report
24/08/202321:30PRNUSInhibikase Therapeutics Announces Development of Novel..
22/08/202321:05PRNUSInhibikase Therapeutics to Present at the International..
21/08/202321:30PRNUSInhibikase Therapeutics Initiates Development of Second..
17/08/202321:30PRNUSInhibikase Therapeutics Announces Completion of the 501..
15/08/202305:20PRNUSInhibikase Therapeutics Reports Second Quarter Financial..
15/08/202305:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/08/202321:05PRNUSInhibikase Therapeutics to Report Second Quarter Financial..
18/07/202306:29EDGAR2Form 8-K - Current report
18/07/202305:05PRNUSInhibikase Therapeutics Regains Compliance with Nasdaq..
06/07/202310:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/07/202310:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/06/202301:15EDGAR2Form 8-K - Current report
29/06/202322:29PRNUSInhibikase Therapeutics Announces a 1-for-6 Reverse Stock..
22/06/202321:05PRNUSInhibikase Therapeutics Announces Selection of the..
21/06/202321:05PRNUSInhibikase Therapeutics Initiates Medical and Patient..
30/05/202321:05PRNUSInhibikase Therapeutics to Present at the LD Micro..
16/05/202320:45PRNUSInhibikase Therapeutics Announces Dosing of First Patient in..
15/05/202321:30PRNUSInhibikase Therapeutics Reports First Quarter Financial..
08/05/202321:05PRNUSInhibikase Therapeutics to Report First Quarter Financial..

최근 히스토리

Delayed Upgrade Clock